Clearday, Inc. Company Profile

Background

Overview

Clearday, Inc. is an innovative longevity healthcare technology company dedicated to providing high-quality, non-acute care solutions that enable aging individuals and those with special needs to live independently and comfortably. The company integrates advanced technologies, including artificial intelligence (AI) and robotics, into personalized care experiences, aiming to enhance the quality of life for its clients. Clearday's mission is to make longevity care more accessible, affordable, and empowering for aging individuals and their families.

Mission and Vision

Clearday's mission is to provide industry-leading longevity care that is more accessible and affordable. The company's vision is to enable aging individuals, those with special needs, and their families to optimize their quality of life across the healthcare continuum: at home, in community centers, during medical visits, and at full and part-time care facilities.

Primary Area of Focus

Clearday focuses on delivering non-acute care services through its Longevity Care Platform, which integrates various health technology innovations into personalized, AI-driven care experiences. The platform continuously assesses an individual's cognitive and physical capabilities to deliver customized care plans.

Industry Significance

The global population of individuals over the age of 60 is projected to double by 2050, resulting in nearly 2.1 billion people. In 2035, the U.S. Census Bureau predicts that for the first time, there will be more Americans over the age of 65 than those under 18. These demographics drive the need for new longevity-tech solutions that provide continuous monitoring, increased engagement, and proactive interventions for older individuals.

Key Strategic Focus

Core Objectives

Clearday aims to revolutionize the longevity care industry by integrating advanced technologies into personalized care solutions, enabling aging individuals to live independently and enhancing the quality of care provided.

Specific Areas of Specialization

• AI-Driven Care Solutions: Developing and implementing AI technologies to create personalized care plans that adapt to the evolving needs of individuals.

• Robotic Companion Care: Introducing autonomous companion robots to provide support and companionship, addressing the shortage of caregivers and enhancing patient engagement.

• Digital Care Platforms: Offering virtual care services through platforms like Clearday at Home™, which provide resources and support for families managing care at home.

Key Technologies Utilized

• Artificial Intelligence (AI): Utilized to assess cognitive and physical capabilities, enabling the creation of customized care plans.

• Robotics: Employed in the form of companion robots to provide autonomous support and companionship to individuals.

• Telehealth and Remote Monitoring: Integrated into the Longevity Care Platform to deliver continuous monitoring and proactive interventions.

Primary Markets or Conditions Targeted

Clearday primarily targets the aging population, individuals with special needs, and those requiring non-acute care services. The company's solutions are designed to support individuals in various settings, including at home, in community centers, during medical visits, and in full and part-time care facilities.

Financials and Funding

Funding History

Clearday has undergone significant financial restructuring to support its strategic initiatives. In March 2024, the company entered into agreements with an institutional lender to amend financing agreements, securing approximately $1.18 million in net financing to cover mortgage and property taxes, along with an additional $263,827 in cash.

Recent Funding Rounds

In March 2023, Clearday announced a proposed merger with Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC). The proposed transaction valued Clearday at $250 million, aiming to accelerate the company's growth and market presence.

Notable Investors

Specific details about individual investors are not publicly disclosed. However, the proposed merger with Viveon Health Acquisition Corp. indicates significant interest from institutional investors in Clearday's business model and growth potential.

Intended Utilization of Capital

The capital raised through financing agreements and the proposed merger is intended to support Clearday's strategic initiatives, including the development and expansion of its AI-driven care solutions, robotic companion care services, and digital care platforms. The company aims to enhance its technological capabilities and market reach to better serve the aging population and individuals with special needs.

Pipeline Development

Key Pipeline Candidates

Clearday's primary focus is on the development and deployment of its Longevity Care Platform, which includes:

• Clearday at Home™: A digital care platform that provides families with resources and support to manage care at home.

• Clearday Clubs™: Membership-based daily care destinations that offer structured engagement and support for individuals with cognitive decline.

• Companion Robotics: Autonomous robots designed to provide companionship and support, addressing caregiver shortages and enhancing patient engagement.

Stages of Clinical Trials or Product Development

As of the latest available information, Clearday is in the development and deployment stages for its digital care platforms and companion robotics. The company has launched Clearday at Home™ and Clearday Clubs™, with plans to expand these services. The companion robotics initiative is in the early stages, with ongoing development and testing.

Target Conditions

Clearday's solutions target conditions associated with aging, including cognitive decline, dementia, and other lifestyle-limiting chronic health conditions. The company's services are designed to support individuals in managing these conditions while maintaining independence and quality of life.

Relevant Timelines for Anticipated Milestones

Specific timelines for upcoming milestones are not publicly disclosed. However, the proposed merger with Viveon Health Acquisition Corp. is expected to accelerate Clearday's growth and market presence, potentially leading to the expansion of its services and technological capabilities.

Technological Platform and Innovation

Proprietary Technologies

• Clearday at Home™: A digital care platform that integrates telehealth, remote monitoring, and patient engagement to support in-home care.

• Companion Robotics: Autonomous robots designed to provide companionship and support, utilizing AI and robotics to enhance patient engagement and address caregiver shortages.

Significant Scientific Methods

• AI-Driven Care Plans: Utilizing machine learning algorithms to continuously assess an individual's cognitive and physical capabilities, enabling the creation of personalized care plans.

• Robotic-Assisted Care: Implementing robotics to provide autonomous companionship and support, enhancing patient engagement and addressing caregiver shortages.

Leadership Team

Executive Profiles

• James Walesa: CEO and Founder of Clearday, with extensive experience in non-acute care and a vision to revolutionize longevity care through technology.

• Jagi Gill: CEO and Chairman of Viveon Health Acquisition Corp., leading the proposed merger with Clearday to accelerate growth and market presence.

Key Contributions or Roles Within the Company

• James Walesa: As CEO and Founder, Walesa has been instrumental in developing Clearday's strategic vision and technological initiatives, including the launch of Clearday at Home™ and the development of companion robotics.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within Clearday's leadership team.

Competitor Profile

Market Insights and Dynamics

The global adult care services market is projected to reach $1.75 trillion by 2026, with an 8.5% compound annual growth rate (CAGR). This growth is driven by the increasing aging population and the demand for innovative care solutions.